Lucid Diagnostics Inc. (LUCD) — Financial statements
Income statement, balance sheet, and cash flow for Lucid Diagnostics Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 5↑8.3% | 4↑79.0% | 2↑544.0% | 0.38↓24.6% | 0.50 | |
| Cost of Revenue | 8↓8.8% | 8↓2.5% | 8↑134.6% | 4↑517.8% | 0.59 | |
| Gross Profit | -3↑27.7% | -4↑35.2% | -6↓86.9% | -3↓3708.2% | -0.09 | |
| Operating Expenses | ||||||
| R&D Expenses | 5,678↑94659.7% | 6↓17.4% | 7↓36.8% | 11↑23.3% | 9 | |
| General & Administrative Expenses | 23,867↑18.4% | 20,156↑104584.7% | 19↓18.7% | 24↑85.4% | 13 | |
| Selling & Marketing Expenses | 17,710↑7.6% | 16,463↑100259.7% | 16↑1.7% | 16↑206.7% | 5 | |
| SG&A Expenses | 41,577↑13.5% | 36,619↑102595.0% | 36↓10.4% | 40↑120.8% | 18 | |
| Other Expenses | -47,208↓29.0% | -36,583↓7653218.0% | -0.48↓129.0% | 2 | 0.00 | |
| Operating Expenses | 47↑11.1% | 42↓0.7% | 42↓19.8% | 53↑93.7% | 27 | |
| Total Costs & Expenses | 54↑7.8% | 50↓1.0% | 51↓10.0% | 57↑102.5% | 28 | |
| Operating Results | ||||||
| Operating Income | -50↓7.8% | -46↑5.0% | -48↑13.7% | -56↓104.9% | -27 | |
| Depreciation & Amortization | 0.87↓25.3% | 1↓53.3% | 2↑29.1% | 2↑48300.0% | 0.00 | |
| EBITDA | -49↓10.0% | -44↑10.9% | -50↑8.3% | -54↓97.8% | -27 | |
| EBIT | -50↓9.1% | -46↑12.9% | -52↑7.0% | -56↓104.9% | -27 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.36↑23.0% | 0.30↑3600.0% | 0.01↓90.0% | 0.08↑112.1% | -0.66 | |
| Interest Income | 0.39↑19.9% | 0.32↓24.1% | 0.42↑381.8% | 0.09 | 0.00 | |
| Interest Expense | 0.02↓15.4% | 0.03↓93.8% | 0.42↑5100.0% | 0.01↓98.8% | 0.66 | |
| Non-Operating Income | 0.00↑100.0% | -0.55↓114.6% | 4 | 0.00 | 0.00 | |
| Other Income / Expenses | -8↓1700.4% | 0.52↑112.5% | -4 | 0.00↑100.0% | -0.66 | |
| Income Before Tax | -58↓27.4% | -46↑13.6% | -53↑6.2% | -56↓100.1% | -28 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -58↓27.4% | -46↑13.6% | -53↑6.2% | -56↓100.1% | -28 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -58↓27.4% | -46↑13.6% | -53↑6.2% | -56↓100.1% | -28 | |
| Bottom-Line Net Income | -71↓33.1% | -53↓0.7% | -53↑6.2% | -56↓100.1% | -28 | |
| EPS (Basic) | -0.69↑34.3% | -1.05↑16.7% | -1.26↑18.7% | -1.55↓98.7% | -0.78 | |
| EPS (Diluted) | -0.69↑34.3% | -1.05↑16.7% | -1.26↑18.7% | -1.55↓98.7% | -0.78 | |
| Weighted Average Shares | 102↑101.8% | 51↑21.0% | 42↑15.4% | 36↑0.3% | 36 | |
| Weighted Average Diluted Shares | 102↑101.8% | 51↑21.0% | 42↑15.4% | 36↑0.3% | 36 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.